Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$2.46B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Amazon
AMZN
|
+$1.13B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.78B |
| 2 |
SNDK
Sandisk
SNDK
|
+$949M |
| 3 |
Advanced Micro Devices
AMD
|
+$926M |
| 4 |
Micron Technology
MU
|
+$585M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$509M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Communication Services | 0.62% |
| 3 | Consumer Discretionary | 0.62% |
| 4 | Industrials | 0.48% |
| 5 | Healthcare | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LITS
13051
CALL
Lite Strategy Inc
LITS
$33.7M
| $19.7K | ﹤0.01% |
21,400
+9,700
| +83% | +$10.1K |
|
|
TRIB
13052
CALL
Trinity Biotech
TRIB
$8.62M
| $19.4K | ﹤0.01% |
1,657
+1,180
| +247% | +$21.8K |
|
13053
CALL
Neonode
NEON
$15.3M
| $19.3K | ﹤0.01% |
20,500
-13,800
| -40% | -$20.5K |
|
13054
PUT
PepGen
PEPG
$217M
| $19.1K | ﹤0.01% |
10,600
-12,100
| -53% | -$19.7K |
|
13055
PSQ Holdings
PSQH
$20.3M
| $18.8K | ﹤0.01% |
+3,118
| New | +$27.6K |
|
13056
CALL
Playboy Inc
PLBY
$146M
| $18.7K | ﹤0.01% |
15,300
-45,500
| -75% | -$69K |
|
13057
PUT
Grove Collaborative
GROV
$41.9M
| $18.5K | ﹤0.01% |
14,800
-300
| -2% | -$369 |
|
|
13058
CALL
PepGen
PEPG
$217M
| $18.4K | ﹤0.01% |
10,200
-412,400
| -98% | -$671K |
|
|
NWAX.WS
13059
New America Acquisition I Corp Warrants
NWAX.WS
| $18.2K | ﹤0.01% |
+30,349
| New | +$16.3K |
|
13060
Yatra Online
YTRA
$62.1M
| $18K | ﹤0.01% |
19,142
-6,625
| -26% | -$6.45K |
|
|
VLOSW
13061
Velos Acquisition I Corp Warrant
VLOSW
$5.75M
| $18K | ﹤0.01% |
+48,574
| New | +$16.8K |
|
13062
SkinHealth Systems
SKIN
$85M
| $17.8K | ﹤0.01% |
25,676
-16,028
| -38% | -$12.3K |
|
13063
CALL
Ispire Technology
ISPR
$85.5M
| $17.7K | ﹤0.01% |
15,800
+2,600
| +20% | +$4.42K |
|
13064
Pliant Therapeutics
PLRX
$71.8M
| $17.6K | ﹤0.01% |
15,480
-37,476
| -71% | -$45.6K |
|
13065
CALL
Coherus Oncology
CHRS
$219M
| $17.6K | ﹤0.01% |
+12,600
| New | +$20.6K |
|
13066
Infobird
IFBD
$8.27M
| $17.6K | ﹤0.01% |
14,922
-9,365
| -39% | -$9.21K |
|
13067
MIRA Pharmaceuticals
MIRA
$32.1M
| $17.6K | ﹤0.01% |
18,566
-6,580
| -26% | -$6.66K |
|
|
UCL
13068
uCloudlink Group
UCL
$14.9M
| $17.6K | ﹤0.01% |
18,891
+4,092
| +28% | +$4.63K |
|
|
COOT
13069
Australian Oilseeds Holdings
COOT
$12.9M
| $17.4K | ﹤0.01% |
+29,952
| New | +$18.4K |
|
13070
Lucid Diagnostics
LUCD
$184M
| $17.2K | ﹤0.01% |
16,118
-87,056
| -84% | -$93.8K |
|
|
THH
13071
TryHard Holdings
THH
$11.9M
| $17K | ﹤0.01% |
+5,874
| New | +$20.3K |
|
|
JAGU
13072
Jaguar Uranium Corp
JAGU
$31.3M
| $16.9K | ﹤0.01% |
+10,119
| New | +$22.4K |
|
|
SUIG
13073
PUT
Sui Group Holdings
SUIG
$83.7M
| $16.6K | ﹤0.01% |
+14,300
| New | +$20.6K |
|
13074
CALL
Westwater Resources
WWR
$77.5M
| $16.5K | ﹤0.01% |
32,400
-206,500
| -86% | -$122K |
|
13075
CALL
Milestone Pharmaceuticals
MIST
$131M
| $16.5K | ﹤0.01% |
+12,300
| New | +$19.7K |
|
Similar funds
Jeff Yass's Q2 2026 Portfolio in Review
As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $142B of net new capital in Q2 2026, opening 1,956 new positions and adding to 5,793 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.78B trimmed.
- Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
- Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
- Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
- Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
- Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
- Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.